Results of study show patients undergoing ASCT for lymphoma, Clonal hematopoiesis of indeterminate potential (CHIP) at the time of transplantation is associated with inferior survival and increased risk of related myeloid neoplasm (TMN), and other adverse outcomes.
Home / Resource Library / Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma